Reference
Owen CN, et al. Delayed immune-related adverse events with anti-PD1-based immunotherapy in melanoma. Annals of Oncology : 30 Mar 2021. Available from: URL: http://doi.org/10.1016/j.annonc.2021.03.204
Rights and permissions
About this article
Cite this article
Anti-PD1-based immunotherapy: risk of delayed immune-related AEs. Reactions Weekly 1850, 7 (2021). https://doi.org/10.1007/s40278-021-93812-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-021-93812-z